A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

SIMPLE SUMMARY: The interest in using Machine-Learning (ML) techniques in clinical research is growing. We applied ML to build up a novel prognostic model from patients affected with Mantle Cell Lymphoma (MCL) enrolled in a phase III open-labeled, randomized clinical trial from the Fondazione Italia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccaria, Gian Maria, Ferrero, Simone, Hoster, Eva, Passera, Roberto, Evangelista, Andrea, Genuardi, Elisa, Drandi, Daniela, Ghislieri, Marco, Barbero, Daniela, Del Giudice, Ilaria, Tani, Monica, Moia, Riccardo, Volpetti, Stefano, Cabras, Maria Giuseppina, Di Renzo, Nicola, Merli, Francesco, Vallisa, Daniele, Spina, Michele, Pascarella, Anna, Latte, Giancarlo, Patti, Caterina, Fabbri, Alberto, Guarini, Attilio, Vitolo, Umberto, Hermine, Olivier, Kluin-Nelemans, Hanneke C, Cortelazzo, Sergio, Dreyling, Martin, Ladetto, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750124/
https://www.ncbi.nlm.nih.gov/pubmed/35008361
http://dx.doi.org/10.3390/cancers14010188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750124/
https://www.ncbi.nlm.nih.gov/pubmed/35008361
http://dx.doi.org/10.3390/cancers14010188

Ejemplares similares